CPT 64642: Neurolytic Injection for Extremity Muscle Spasm
Medicare pays $168 and commercial payers pay $463 on average nationally for this procedure.
CPT code 64642 describes injection of a chemical neurolytic agent (for example, Botox®) into one to four muscles of a single extremity to relieve pain and muscle spasms; this is a minor procedural pain-management service typically performed in an outpatient clinic, ambulatory surgical center, or office-based procedure setting under local anesthesia or monitored anesthesia care.
For related coverage guidance, see recent payer policy updates: Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders.
Customize your policy alerts
Sign up for cpt 64642 policy alerts
Get alerted when payer policies referencing 64642 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Medicare's mean rate for CPT 64642 sits at $167.50, while BUCA’s average commercial mean is substantially higher at $463.00; this highlights a clear gap between federal reimbursement and average commercial contracting levels. Blue Cross Blue Shield ($664.10 mean) and UnitedHealth Group ($237.00 mean) also sit above Medicare, with Cigna ($222.30 mean) and Aetna ($125.50 mean) spanning the middle-to-lower portions of the national spectrum.
Examining dispersion using the interquartile spread (P75–P25), Blue Cross Blue Shield has the widest spread at $290.90 ($800.20–$541.00), indicating the greatest variability among commercial contracts. Aetna is the tightest at $96.20 ($162.20–$63.40), followed by Cigna at $132.00 ($276.20–$145.20). UnitedHealth Group’s spread is $142.70 ($293.90–$151.20), and BUCA’s interquartile spread is $201.40 ($561.90–$360.50).